Scopio X100HT
Created for hematology labs with high throughput requirements, Scopio X100HT gives labs reliable and accelerated diagnostic capabilities.
Scopio Labs
Scopio Labs was founded by two physicists and visionaries determined to push the boundaries of medicine and innovate in a way that would do some good in the world. Early in their careers, Itai Hayut and Erez Na’aman dreamed of a collaboration. After witnessing medical practitioners in the hematology lab who still rely on analog, outdated and labor-intensive practices using traditional microscopes and manual cell counts, they realized that with their backgrounds in physics, IT and medical device technology and the evolution of deep learning, they could use AI-powered analysis to bring microscopy and hematology into the digital age. All they needed was to find a scanner to digitize the slides, and the rest would fall into place. But no such scanner existed, and so that’s where the Scopio story began. The result is a series of innovations that brings high-quality data and advancements in deep learning to the practice of hematology, transforming the future of disease detection and diagnosis forever.
Scopio X100
Our Full-Field Peripheral Blood Smear Application is the first fully digital platform for small and medium labs that replaces the manual microscope.
Full-Field Peripheral Blood Smear Application
The Full-Field Peripheral Blood Smear™ (FF-PBS) Application on Scopio’s X100 and X100HT platforms is an end-to-end digital cell morphology solution that supplants the manual microscope review.
Browse Products by Field
Scopio Labs was founded by two physicists and visionaries determined to push the boundaries of medicine and innovate in a way that would do some good in the world. Early in their careers, Itai Hayut and Erez Na’aman dreamed of a collaboration. After witnessing medical practitioners in the hematology lab who still rely on analog, outdated and labor-intensive practices using traditional microscopes and manual cell counts, they realized that with their backgrounds in physics, IT and medical device technology and the evolution of deep learning, they could use AI-powered analysis to bring microscopy and hematology into the digital age. All they needed was to find a scanner to digitize the slides, and the rest would fall into place. But no such scanner existed, and so that’s where the Scopio story began. The result is a series of innovations that brings high-quality data and advancements in deep learning to the practice of hematology, transforming the future of disease detection and diagnosis forever.